Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 43 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PALL LIFE SCIENCES BELGIUM from Hoegaarden, company number BE0407606965, closed financial year 2025 with a result of € 46.7 million after tax. For that financial year PALL LIFE SCIENCES BELGIUM recorded revenue of € 111 million and equity of € 139.8 million. Compared with financial year 2024, the result moved from € 30.6 million to € 46.7 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ 139.8 million
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 46.7 million
▲ 52% vs 2024
Profit after tax over the fiscal year.
€ 81 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
289.7
▲ 5.9 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 26.1 million
▲ 9% vs 2024
€ 90,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 472,443
▲ 97% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 9.5 million
▼ 71% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 58 days on average.
€ 4 million
▼ 75% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 216,441,390 | € 114,495,033 | € 85,934,874 | € 111,033,314 | ▲ 29% |
| Profit after taxes | € 52,635,181 | € 15,550,459 | € 30,631,622 | € 46,667,626 | ▲ 52% |
| Equity | € 80,262,572 | € 95,813,031 | € 126,444,653 | € 139,817,153 | ▲ 11% |
| Total debts | € 34,287,780 | € 55,356,336 | € 49,507,125 | € 70,890,962 | ▲ 43% |
| Cash | € 21,814,757 | - | - | - | |
| Land & buildings | € 7,733,873 | € 7,415,269 | € 14,573,570 | € 14,284,778 | ▼ 2% |
| Retained profit | € 56,963,193 | € 72,513,652 | € 103,145,274 | € 68,812,899 | ▼ 33% |
| Dividend | € 65,000,000 | € 0 | € 0 | € 81,000,000 | |
| Bank debt | € 0 | € 35,871,710 | € 2,063 | € 0 | ▼ 100% |
| Balance sheet total | € 114,645,818 | € 151,169,367 | € 175,951,778 | € 210,708,115 | ▲ 20% |
| Employees (FTE) | 422.2 | 351.9 | 283.8 | 289.7 | ▲ 5.9 |
Key figures of PALL LIFE SCIENCES BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PALL LIFE SCIENCES BELGIUM?
What happened at PALL LIFE SCIENCES BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 46.7 million (▲ 52% vs 2024). Source: NBB ↗
- Bernard Goethals became a director. NBB
- Steven Vanhamel became a director. NBB
- Bart Van Aken became a director. NBB
- New establishment in Tienen. KBO
- New establishment in Hoegaarden. KBO
- Start of the company according to the CBE. KBO
In short
From € 52.6 million profit in 2022 to € 46.7 million profit in 2025.
Paid € 27.2 million in corporate taxes since 2022.
Best year ever: 2022, with € 52.6 million profit.
Paid out € 146 million in dividends to the owners in total.
Management
Behind PALL LIFE SCIENCES BELGIUM are Bernard Goethals, Bart Van Aken and Steven Vanhamel. The shares are held by Pall Schweiz (Gmbh) (100%). It owns 100% of Cytiva Hong Kong Limited, 100% of Leica Microsystems Belgium, 100% of Pall Artelis, 100% of Pall Belgium and 100% of Cytiva Belgium itself.
Directors
According to the 2025 annual accounts
since 2026
since 2018
since 2021
Shareholders
Pall Schweiz (Gmbh)
100%
Participations
Cytiva Hong Kong Limited
100%
100%
100%
100%
Establishments
Establishment units
Physical locations of this company
Reugelstraat 2
3320 Hoegaarden
Hamelendreef 66
3300 Tienen
Active since 1 January 2016
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Domain
Domain
cytivalifesciences.com
Registered
2019-08-16
Registrar
CSC Corporate Domains, Inc.
Expires
2026-08-16
Website info
Features
Details
- Company number
- 0407.606.965
- VAT number
- BE 0407.606.965
- Registered office
- Reugelstraat 2, 3320 Hoegaarden
- Names & denominations
- PALL LIFE SCIENCES BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 November 1970
- Peppol
- Active · Active since 4 Feb 2026
- Contact
- cytivalifesciences.com
- Activities · NACE
Vervaardiging van verpakkingsmateriaal van kunststof
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van papier en karton
Vervaardiging van papier